Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States
出版年份 2017 全文链接
标题
Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States
作者
关键词
-
出版物
JOURNAL OF MEDICAL ECONOMICS
Volume 20, Issue 7, Pages 723-731
出版商
Informa UK Limited
发表日期
2017-04-21
DOI
10.1080/13696998.2017.1320559
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
- (2016) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry
- (2015) Emily C. O'Brien et al. AMERICAN HEART JOURNAL
- Heart Disease and Stroke Statistics—2016 Update
- (2015) Dariush Mozaffarian et al. CIRCULATION
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
- (2015) Ankur Pandya et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland
- (2015) Piia K. Rannanheimo et al. VALUE IN HEALTH
- Cardiovascular Risk and Statin Use in the United States
- (2014) M. E. Johansen et al. ANNALS OF FAMILY MEDICINE
- Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
- (2014) R Ara et al. HEALTH TECHNOLOGY ASSESSMENT
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- The State of US Health, 1990-2010
- (2013) Christopher J. L. Murray JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Forecasting the Future of Stroke in the United States: A Policy Statement From the American Heart Association and American Stroke Association
- (2013) B. Ovbiagele et al. STROKE
- Efficacy and Safety of Vorapaxar in Patients With Prior Ischemic Stroke
- (2013) David A. Morrow et al. STROKE
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Forecasting the Future of Cardiovascular Disease in the United States
- (2011) Paul A. Heidenreich et al. CIRCULATION
- Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia
- (2011) F. van Nooten et al. Netherlands Heart Journal
- Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
- (2010) Deepak L. Bhatt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study
- (2010) John Reckless et al. VALUE IN HEALTH
- Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications
- (2009) Roberta Ara et al. American Journal of Cardiovascular Drugs
- Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: Economic analysis of the aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE) study
- (2009) C. Daniel Mullins et al. CLINICAL THERAPEUTICS
- Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland
- (2009) Erkki J.O. Soini et al. CURRENT MEDICAL RESEARCH AND OPINION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started